safrole oxide has been researched along with Infections, Staphylococcal in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Aguado, JM; Aguirregabiria, M; Benítez, RM; Berbel, D; Boix-Palop, L; Calbo, E; Carratala, J; Cobo, S; Cuervo, G; Domínguez, MÁ; Euba, G; Garcia-Pais, MJ; Garcia-Pardo, G; Gasch, O; Gioia, F; Gomez-Zorrilla, S; Gomila-Grange, A; Grillo, S; Hereu, P; Horna, G; Iftimie, S; Jover-Sáenz, A; Loeches-Yagüe, MB; López-Contreras, J; López-Cortés, LE; Meije, Y; Miro, JM; Morata, L; Oriol, I; Padullés, A; Pallarés, N; Paño, JR; Pedro-Botet, ML; Pérez-Rodríguez, MT; Pujol, M; San-Juan, R; Tebe, C; Videla, S | 1 |
1 trial(s) available for safrole oxide and Infections, Staphylococcal
Article | Year |
---|---|
Multicentre, randomised, open-label, phase IV-III study to evaluate the efficacy of cloxacillin plus fosfomycin versus cloxacillin alone in adult patients with methicillin-susceptible
Topics: Adult; Bacteremia; Cloxacillin; Fosfomycin; Humans; Methicillin; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Safrole; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome | 2021 |